Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5172) 5172
Book Chapter (112) 112
Magazine Article (33) 33
Newsletter (16) 16
Newspaper Article (16) 16
Book / eBook (5) 5
Reference (3) 3
Web Resource (3) 3
Conference Proceeding (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3958) 3958
science & technology (3602) 3602
life sciences & biomedicine (3400) 3400
clostridium difficile (2197) 2197
male (1860) 1860
female (1836) 1836
anti-bacterial agents - therapeutic use (1417) 1417
infectious diseases (1363) 1363
clostridium infections - drug therapy (1247) 1247
aged (1224) 1224
middle aged (1207) 1207
microbiology (1126) 1126
adult (1030) 1030
antibiotics (1008) 1008
clostridium difficile - isolation & purification (990) 990
biological and medical sciences (961) 961
medical sciences (894) 894
risk factors (894) 894
health aspects (833) 833
clostridium infections - microbiology (818) 818
diarrhea (804) 804
animals (797) 797
clostridium difficile - drug effects (767) 767
enterocolitis, pseudomembranous - drug therapy (752) 752
infections (644) 644
aged, 80 and over (620) 620
enterocolitis, pseudomembranous - microbiology (614) 614
treatment outcome (609) 609
abridged index medicus (586) 586
pharmacology & pharmacy (565) 565
clostridium infections (563) 563
diarrhea - microbiology (562) 562
feces - microbiology (556) 556
clostridium infections - epidemiology (549) 549
bacteria (499) 499
gastroenterology & hepatology (494) 494
research (475) 475
vancomycin - therapeutic use (471) 471
retrospective studies (470) 470
anti-bacterial agents - adverse effects (469) 469
recurrence (461) 461
care and treatment (444) 444
microbiota (440) 440
immunology (433) 433
anti-bacterial agents - pharmacology (428) 428
clostridium infections - diagnosis (425) 425
general & internal medicine (417) 417
clostridium difficile - pathogenicity (404) 404
pharmacology. drug treatments (384) 384
drug therapy (380) 380
metronidazole - therapeutic use (379) 379
adolescent (358) 358
medicine, general & internal (356) 356
clostridium difficile infection (351) 351
mortality (349) 349
antibacterial agents (343) 343
bacterial diseases (342) 342
enterocolitis, pseudomembranous - epidemiology (341) 341
incidence (330) 330
epidemiology (329) 329
enterocolitis, pseudomembranous - diagnosis (326) 326
hospitals (324) 324
anti-bacterial agents - administration & dosage (318) 318
diarrhea - drug therapy (316) 316
analysis (311) 311
clostridium infections - therapy (311) 311
colitis (311) 311
vancomycin (310) 310
microbial sensitivity tests (307) 307
cross infection - microbiology (304) 304
human bacterial diseases (303) 303
medicine (302) 302
clostridium (294) 294
inflammatory bowel disease (288) 288
cross infection - epidemiology (287) 287
clostridium difficile - genetics (285) 285
young adult (279) 279
antibiotics. antiinfectious agents. antiparasitic agents (273) 273
research article (273) 273
child (271) 271
patients (264) 264
internal medicine (263) 263
surgery (261) 261
toxins (260) 260
clostridium infections - complications (256) 256
nosocomial infections (247) 247
diagnosis (236) 236
metronidazole (236) 236
public, environmental & occupational health (231) 231
medicine & public health (229) 229
bacterial diseases of the digestive system and abdomen (226) 226
clostridium infections - prevention & control (226) 226
gastroenterology. liver. pancreas. abdomen (225) 225
infection (222) 222
bacterial infections (221) 221
mice (221) 221
clostridium perfringens (215) 215
probiotics (215) 215
infectious disease (214) 214
prospective studies (210) 210
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5112) 5112
German (73) 73
French (48) 48
Spanish (48) 48
Russian (28) 28
Japanese (25) 25
Polish (18) 18
Portuguese (14) 14
Czech (12) 12
Italian (11) 11
Danish (10) 10
Dutch (7) 7
Hungarian (7) 7
Korean (6) 6
Romanian (4) 4
Serbian (4) 4
Chinese (3) 3
Hebrew (3) 3
Norwegian (3) 3
Bulgarian (1) 1
Finnish (1) 1
Icelandic (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection
by Falcone, Marco and Russo, Alessandro and Iraci, Federica and Carfagna, Paolo and Goldoni, Paola and Vullo, Vincenzo and Venditti, Mario
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 252 - 257
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Coinfection | Humans | Gram-Positive Bacterial Infections - mortality | Bacteremia - mortality | Male | Enterococcus - growth & development | Clostridium Infections - microbiology | Cross Infection - pathology | Gram-Positive Bacterial Infections - microbiology | Candidiasis - pathology | Clostridium Infections - mortality | Odds Ratio | Enterobacteriaceae - growth & development | Enterobacteriaceae Infections - microbiology | Risk Factors | Bacteremia - drug therapy | Cross Infection - drug therapy | Gram-Positive Bacterial Infections - pathology | Candida - pathogenicity | Vancomycin - therapeutic use | Cross Infection - microbiology | Enterobacteriaceae - drug effects | Enterococcus - pathogenicity | Survival Analysis | Clostridium Infections - drug therapy | Enterococcus - drug effects | Gram-Positive Bacterial Infections - drug therapy | Bacteremia - pathology | Clostridium difficile - drug effects | Enterobacteriaceae Infections - drug therapy | Multivariate Analysis | Cross Infection - mortality | Candidiasis - microbiology | Case-Control Studies | Bacteremia - microbiology | Clostridium Infections - pathology | Candidiasis - drug therapy | Metronidazole - therapeutic use | Female | Candida - growth & development | Enterobacteriaceae - pathogenicity | Enterobacteriaceae Infections - mortality | Anti-Infective Agents - therapeutic use | Candidiasis - mortality | Treatment Outcome | Enterobacteriaceae Infections - pathology | Clostridium difficile - pathogenicity | Clostridium difficile - growth & development | Aged | Candida - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis
by Baur, David, MD and Gladstone, Beryl Primrose, PhD and Burkert, Francesco, MD and Carrara, Elena, MD and Foschi, Federico, MD and Döbele, Stefanie, MD and Tacconelli, Evelina, Prof
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 9, pp. 990 - 1001
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Bacterial Infections - drug therapy | Cross Infection - prevention & control | Gram-Negative Bacteria | Humans | Drug Resistance, Bacterial | Practice Patterns, Physicians | Clostridium Infections - epidemiology | Clostridium difficile - isolation & purification | Clostridium Infections - prevention & control | Cross Infection - drug therapy | Incidence | Methicillin-Resistant Staphylococcus aureus | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - prevention & control | beta-Lactamases | Clostridium Infections - drug therapy | Cross Infection - epidemiology | Medical research | Drug resistance in microorganisms | Analysis | Long-term care of the sick | Medicine, Experimental | Bacteria | Health aspects | Antibacterial agents | Medical care, Cost of | Intervention | Clinical trials | Systematic review | Long term health care | Infections | Vancomycin | Drug resistance | Clinical outcomes | Methicillin | Literature reviews | Heterogeneity | Audits | E coli | Antibiotic resistance | Aminoglycoside antibiotics | Gram-negative bacteria | Bacterial infections | Hospital costs | Staphylococcus infections | Long-term care | Meta-analysis | Studies | Antibiotics | Hygiene | Colonization | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
by Kathleen M. Mullane and Mark A. Miller and Karl Weiss and Arnold Lentnek and Yoav Golan and Pamela S. Sears and Youe-Kong Shue and Thomas J. Louie and Sherwood L. Gorbach
Clinical infectious diseases, ISSN 1058-4838, 9/2011, Volume 53, Issue 5, pp. 440 - 447
Clostridium | Health outcomes | Infectious diseases | Antibiotics | Clostridium difficile | Penicillin | Diarrhea | Infections | Colitis | ARTICLES AND COMMENTARIES | Dosage | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Bacterial diseases of the digestive system and abdomen | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Other diseases. Semiology | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Male | Enterocolitis, Pseudomembranous - etiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Enterocolitis, Pseudomembranous - drug therapy | Vancomycin - therapeutic use | Adolescent | Aged, 80 and over | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Aminoglycosides - therapeutic use | Clostridium infections | Patient outcomes | Fidaxomicin | Dosage and administration | Research | Vancomycin | Drug therapy | Clinical trials | Side effects | Bacterial infections | Effectiveness studies | Index Medicus | and Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antimicrobial therapy of acute diarrhoea: a clinical review
by Lübbert, Christoph
Expert review of anti-infective therapy, ISSN 1478-7210, 02/2016, Volume 14, Issue 2, pp. 193 - 206
colonisation | infection | gastroenteritis | Clostridium difficile | Antimicrobial therapy | GI tract | diarrhoea | resistance | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Campylobacter Infections - diagnosis | Humans | Salmonella Infections - diagnosis | Gastroenteritis - drug therapy | Anti-Bacterial Agents - therapeutic use | Rifamycins - therapeutic use | Cholera - drug therapy | Campylobacter Infections - drug therapy | Enterocolitis, Pseudomembranous - diagnosis | Escherichia coli Infections - drug therapy | Salmonella Infections - drug therapy | Acute Disease | Escherichia coli Infections - diagnosis | Dysbiosis - chemically induced | Bacterial Infections - drug therapy | Cholera - diagnosis | Ciprofloxacin - therapeutic use | Dysentery, Bacillary - diagnosis | Yersinia Infections - drug therapy | Dysentery, Bacillary - drug therapy | Yersinia Infections - diagnosis | Enterocolitis, Pseudomembranous - drug therapy | Azithromycin - therapeutic use | Shiga-Toxigenic Escherichia coli | Diarrhea - drug therapy | Bacterial Infections - diagnosis | Aminoglycosides - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fidaxomicin versus Vancomycin for Clostridium difficile Infection
by Louie, Thomas J and Miller, Mark A and Mullane, Kathleen M and Weiss, Karl and Lentnek, Arnold and Golan, Yoav and Gorbach, Sherwood and Sears, Pamela and Shue, Youe-Kong and OPT-80-003 Clinical Study Grp and OPT-80-003 Clinical Study Group
The New England journal of medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 5, pp. 422 - 431
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Other diseases. Semiology | Antibiotics. Antiinfectious agents. Antiparasitic agents | Clostridium difficile - classification | Prospective Studies | Humans | Middle Aged | Male | Secondary Prevention | Clostridium difficile - isolation & purification | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Aminoglycosides - pharmacokinetics | Double-Blind Method | Treatment Outcome | Vancomycin - adverse effects | Enterocolitis, Pseudomembranous - drug therapy | Vancomycin - pharmacokinetics | Vancomycin - therapeutic use | Anti-Bacterial Agents - pharmacokinetics | Intention to Treat Analysis | Clostridium Infections - drug therapy | Aged | Aminoglycosides - adverse effects | Clostridium difficile - drug effects | Aminoglycosides - therapeutic use | Vancomycin | Antibiotics | Clostridium infections | Comparative analysis | Drug therapy | Health aspects | Clinical trials | Infections | Manuscripts | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
by Cohen, Stuart H and Gerding, Dale N and Johnson, Stuart and Kelly, Ciaran P and Loo, Vivian G and McDonald, L. Clifford and Pepin, Jacques and Wilcox, Mark H and Infectious Diseases Society of America and Society for Healthcare Epidemiology of America
Infection control and hospital epidemiology, ISSN 0899-823X, 05/2010, Volume 31, Issue 5, pp. 431 - 455
Public, Environmental & Occupational Health | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Enterocolitis, Pseudomembranous - epidemiology | Humans | Clostridium Infections - epidemiology | Infection Control - methods | Cross Infection - drug therapy | Enterocolitis, Pseudomembranous - drug therapy | Cross Infection - diagnosis | Adult | Clostridium Infections - drug therapy | Enterocolitis, Pseudomembranous - diagnosis | Clostridium Infections - diagnosis | Clostridium difficile - drug effects | Cross Infection - epidemiology | Index Medicus | Nursing
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection
by McDonald, Emily G and Milligan, Jonathon and Frenette, Charles and Lee, Todd C
JAMA internal medicine, ISSN 2168-6106, 03/2015, Volume 175, Issue 5, pp. 784 - 791
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Age Factors | Cross Infection - etiology | Humans | Middle Aged | Inappropriate Prescribing - statistics & numerical data | Clostridium Infections - etiology | Male | Inappropriate Prescribing - prevention & control | Clostridium Infections - epidemiology | Secondary Prevention - methods | Incidence | Anti-Bacterial Agents - therapeutic use | Canada - epidemiology | Clostridium Infections - physiopathology | Female | Retrospective Studies | Clostridium Infections - therapy | Clostridium Infections - diagnosis | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Cross Infection - therapy | Inappropriate Prescribing - adverse effects | Cross Infection - physiopathology | Risk Factors | Proton Pump Inhibitors - therapeutic use | Withholding Treatment | Secondary Prevention - statistics & numerical data | Anti-Bacterial Agents - classification | Cross Infection - diagnosis | Aged | Clostridium difficile - drug effects | Complications and side effects | Care and treatment | Relapse | Clostridium infections | Proton pump inhibitors | Dosage and administration | Risk factors | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights